Back to Journals » Neuropsychiatric Disease and Treatment » Volume 18

Development and Reliability Testing of the Stroke Patient Protection Motivation Scale

Authors Han C, Zhang L, Liu J

Received 8 December 2021

Accepted for publication 9 April 2022

Published 4 July 2022 Volume 2022:18 Pages 1341—1349

DOI https://doi.org/10.2147/NDT.S353111

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Yuping Ning



Chunjie Han,1,* Lingli Zhang,2,* Jihong Liu2

1Department of Rehabilitation Medicine, Beijing Luhe Hospital of China Capital Medical University, Beijing, 101149, People’s Republic of China; 2Department of Neurology, Beijing Luhe Hospital of China Capital Medical University, Beijing, 101149, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Jihong Liu, Department of Neurology, Beijing Luhe Hospital of China Capital Medical University, Beijing, 101149, People’s Republic of China, Tel +86 10 69543901-1041, Fax +86 10 69531069, Email [email protected]

Objective: A scale for evaluating the protective motivation of patients who had suffered a stroke was developed to preliminarily verify the reliability of the scale and provide scientific measurement tools for clinical professionals.
Methods: A descriptive research design method was adopted. First, an initial draft of the questionnaire was formed by conducting a literature review supplemented by semi-structured interviews and modified using the Delphi method. A total of 287 patients who had suffered a stroke were selected for the formal survey using the convenience sampling method. Further item screening was performed using an item analysis and an exploratory factor analysis, and reliability testing was also performed.
Results: The scale consisted of 34 entries in the following 6 dimensions: severity, susceptibility, internal and external rewards, response efficacy, response cost and self-efficacy. The overall Cronbach’s alpha coefficient was 0.935, with correlation coefficients between dimensions and total scale scores ranging from 0.604 to 0.805 (P < 0.05) and correlation coefficients between dimensions ranging from 0.154 to 0.537 (P < 0.05).
Conclusion: The protective motivation scale prepared in this study was tested and had good reliability, so this scale can be used as a scientific tool to evaluate the implementation of secondary prevention strategies for protective motivation of patients who have suffered a stroke.

Keywords: stroke, protection motivation, health belief

Introduction

Stroke is an acute cerebrovascular disease caused by stenosis, occlusion or rupture of an artery in the brain due to various predisposing factors, resulting in an acute cerebral blood circulation disorder and limited or diffuse cerebral deficits. It is divided into two types: ischaemic stroke and haemorrhagic stroke. According to the latest Global Burden of Disease study1 and the latest report on stroke prevention and control in China,2 stroke is the second leading cause of death in the global population and the first cause of death and disability in China. About 3 million strokes occur each year in China, with an average of 1 stroke every 10 seconds;3 an average of 1 in 5 deaths is caused by a stroke,2 and the cumulative disability rate is 30% over 3 months.4 It is worth noting that the risk of a recurrent stroke is as high as 53% within 5 years, and recurrent strokes account for approximately one-third of all stroke cases.5 Compared with a first stroke, recurrent stroke often causes aggravation of neurological dysfunction in patients.6–9 Studies have shown that providing earlier and more intensive secondary prevention strategies to patients who have had a stroke can significantly reduce the risk of adverse outcomes.10,11 According to the latest bibliometric analysis,12 more than 93% of the studies related to secondary prevention strategy adherence of patients who have had a stroke in China within the past 12 years have focused on secondary prevention medication, and less than 7% of the studies involved daily behavioural changes or lifestyle modifications related to secondary prevention.

Intervention of behavioural intentions is crucial for behavioural change, and the protection motivation theory (PMT) is widely used in the study of behavioural intentions as well as the prediction of actual behaviours. The PMT consists of three parts: information source, cognitive mediation and coping mode. Through threat and coping assessment, the PMT can help generate self-protection motivation and establish behaviour,13 and it can also explain and predict behavioural changes in patients.14 Therefore, if the PMT can be optimised and the self-management behaviour of patients who have had a stroke can be improved, accelerated patient rehabilitation and a reduction in recurrence are expected. This study aimed to develop an assessment scale of protection motivation for patients who had suffered a stroke using the PMT as a framework and tested the preliminary reliability of the scale, providing a scientific measurement tool and reference for explaining and predicting the possibility of adopting secondary prevention health behaviours in patients who suffer strokes.

Subjects and Methods

Research Participants

Convalescent patients who had suffered a stroke in the neurology and rehabilitation wards of three tertiary general hospitals in Beijing from December 2020 to March 2021, as well as home patients who had suffered a stroke and returned for follow-up visits to the neurology clinic, were studied. All patients signed informed consent forms for inclusion in this study, and the study was approved by the hospital ethics committee.

The inclusion criteria were as follows: (1) patients with at least one stroke occurrence that met the fourth national diagnostic criteria of cerebrovascular disease in 1995 and was confirmed by a cranial computed tomography or magnetic resonance imaging; (2) patients ≥18 years old; (3) a Barthel index score ≥60; (4) patients with clear consciousnesses and no cognitive impairments; (5) patients that agreed to this survey and were willing to cooperate.

The exclusion criteria were as follows: (1) patients with severe aphasia; (2) patients with severe cognitive dysfunction; (3) patients with a personal or family history of psychiatric disorders; (4) patients with a severe illness or an unstable physical status.

The sample size was calculated by considering the number of items in the initial version of the scale and the statistical methods used to determine the sample size for the formal survey of this study. Most scholars believe that the ratio of the number of items to the sample size should be 1:5 to 1:10 for factor analysis.15 The number of items in the initial version of the scale in this study was 41, so the sample size for this formal survey needed to be 205–410.

Methods

Sample Collection

In this study, the convenient sampling method was used to collect the data of three third grade hospitals in Beijing from December 2020 to March 2021. The subjects were stroke patients in the rehabilitation period in the Department of Neurology and Rehabilitation wards of general hospitals and stroke patients at home; those that met the inclusion criteria were selected for the study sample, which included two types of patient data: socio-demographic and disease-related. Socio-demographic data included the patients’ age, gender, marital status, residence, education level, per capita monthly household income, medical payment method and occupational status; disease-related data included the stroke duration, stroke type, number of strokes, underlying disease and the Barthel index score.

The Initial Questionnaire Design

The scale items were initially constructed by reviewing literatures and searching in well-known Chinese and English databases, such as Wanfang, China National Knowledge Infrastructure (CNKI), Wipu (VIP), PubMed, Web of Science, etc., using protective motivation, protective motivation theory, health belief, health belief model, health belief theory, scale and questionnaire as the primary search terms. A total of 4100 articles (1393 in Chinese and 2707 in English) were retrieved from the primary Chinese and English databases. Among them, 203 repeated references were removed (118 in Chinese and 85 in English), and after a preliminary reading of titles and abstracts, 3689 unrelated articles (1235 in Chinese and 2454 in English) were excluded. After reviewing the entire texts again, 58 more articles were excluded and 58 articles were retained. The scale dimensions and items were used as a reference for the preliminary item pool of the scale. The survey was supplemented by semi-structured interview scale projects, and clinical and medical experts in the field of stroke care, mental and psychological care and higher education of stroke health care were invited to modify the scale projects through the Delphi method.16 Otherwise stated, the back-to-back communication was used to solicit the forecast opinions of the members of the expert group. After several occasions of consultation and feedback, the expert groups’ opinions gradually tended to be concentrated, and finally, the collective judgment results with high accuracy were obtained. The initial version of the Protection Motivation Assessment Scale consisted of 7 dimensions and 41 items. The severity dimension contained 6 items, the susceptibility dimension contained 5 items, the internal reward dimension contained 6 items (reverse scoring), the external reward dimension contained 5 items (reverse scoring), the response cost dimension contained 6 items (reverse scoring), the response efficacy dimension contained 6 items and the self-efficacy dimension contained 7 items. The total score of the initial version of the scale ranged from 51 to 205, with higher scores indicating higher levels of patients’ motivation to protect.

The Formation of the Formal Questionnaire

The data collected through the questionnaire were analysed using the Pearson correlation, exploratory factor analysis (EFA) and reliability and validity analysis to form the final questionnaire.

Quality Control

Questionnaires were distributed by highly trained postgraduate students studying the field of cerebrovascular disease nursing. All data entry was performed by a designated person and checked by two persons. The Excel 2020 and SPSS 20.0 software were used for data entry and statistics. The questionnaire data were entered and removed on the same day; following data entry, all information was confirmed by checking the rationality and logic and rechecking the original scales.

Data Analysis

The data were analysed using the SPSS 20.0 software, and the internal consistency of the scale was evaluated using Cronbach’s alpha, and the validity of the scale was analysed using EFA and correlation coefficients between the dimensions and the total scale. A P value of <0.05 was considered a statistically significant difference.

Results

Basic Information

In this study, 300 questionnaires were distributed and 287 valid questionnaires were returned, with a valid return rate of 95.7%. Among the participants, 171 (60%) were male and 116 (40%) were female. The age of the patients ranged from 29 to 89 years old, with a mean age of 64.84 ± 11.02 years old and the stroke durations ranged from 0.33 to 19 years, with a median duration of 1.5 (0.33, 6.00) years.

Scale Item Analysis

Correlation Analysis of the Scale Question Items with the Total Scale

The correlation coefficients between the scale items and the total scale showed that although items A4, B5 and C6 correlated with the total score at a significant level (P < 0.05), the correlation coefficient of r < 0.40 with the total score did not meet the requirements and was considered for deletion. See Table 1.

Table 1 Correlation Analysis Between Scale Items and Total Scale

Commonality of the Scale Items and Factor Loadings

A principal components analysis was performed on the scale items, with a limit of one factor extracted. One common factor eigenvalue of 12.482 explained 30.313% of the total variance. From the results of the factor analysis, it was found that items A4, B5, C1 and C6 with factor loadings <0.45 or entries with a commonality <0.20 were considered for deletion. See Table 2.

Table 2 Commonality of Scale Items and Factor Loadings

Summary of the Study Analysis

In the analysis of this research project, the three entries of A4, B5, and C6 were selected respectively for 4 times, 4 times and 3 times and they were deleted in the end. The initial version of the scale retained 38 items after analysis to filter the items.

Scale Validity Analysis

Structural Validity

Exploratory Factor Analysis

The statistical results showed that the Kaiser–Meyer–Olkin (KMO) value of this study was 0.879 > 0.60, and the Bartlett’s sphericity test approximation χ2 was 8210.598 (P < 0.05), which was suitable for factor analysis. A total of eight factors with eigenvalues >1 were extracted by the first EFA, and their cumulative variance contribution was 73.404%. Items with less than three factor compositions where they were located, loadings on all factors that did not reach 0.45 or items with large loadings on two or more factors were removed, and items B4, C3, D5 and D3 that did not meet the criteria were removed and then followed by a second EFA. The KMO value was 0.877 > 0.60 by the second EFA, and Bartlett’s sphericity test showed a statistical significance (P < 0.05). The same method was used to extract six common factors with eigenvalues >1, with a cumulative variance contribution of 71.820%, and the structure was generally consistent with the dimensional conceptions of the scale development. Each item achieved a loading of 0.45 on each factor. The total variance interpretation of the second EFA is shown in Table 3, and the rotated factor component matrix is shown in Table 4.

Table 3 Explanation of the Total EFA Variance

Table 4 Load Matrix After EFA Rotation

Naming the Factors

The factors were named according to the meaning of the items under each factor. Factor 1 contained six items, E1 to E6, which described the benefits that patients perceived from adopting protection behaviours of secondary prevention, such as the effectiveness of medication compliance in preventing stroke recurrence and improving prognosis; this factor was named “response efficacy”. Factor 2 contained seven items, C1, C2, C4, C5, D1, D2 and D4, which described the benefits that patients perceived from adopting risky behaviours, such as psychological satisfaction or social help from smoking or drinking for patients; this factor was named “internal and external rewards”. Factor 3 contained six items, F1 to F6, which described patients’ perceived barriers to implementing secondary prevention protective behaviours, such as patients’ perceived effort required to adhere to healthy dietary habits; this factor was named “response cost”. Factor 4 contained seven items, G1 to G7, which described patients’ ability and confidence to pre-implement secondary prevention protective behaviours on their own; this factor was named “self-efficacy”. Factor 5 contained five items, A1, A2, A3, A5 and A6, which described the severity of patients’ perceived stroke recurrence; this factor was named “severity”. Factor 6 contained three items, B1 to B3, describing patients’ perceived likelihood of stroke recurrence; this factor was named “susceptibility”. After two exploratory factor analyses, an official version of the Stroke Patient Protection Motivation Scale with 6 dimensions and 34 items was developed, with a total score of 34–170. The higher the score, the higher the level of patient protection motivation and the stronger the patient’s behavioural intention and likelihood of performing secondary prevention behaviours.

Correlation Analysis of the Dimensions and the Total Scale

Correlation between the dimensions and their correlations with the total scale were analysed using correlations. The correlation coefficients (r) between the dimensions and the total scale scores ranged from 0.604 to 0.805 (P < 0.05), and r between the dimensions ranged from 0.154 to 0.537 (P < 0.05). See Table 5.

Table 5 Correlation Matrix Between Dimensions and Their Correlation with the Total Scale

Scale Reliability

The total Cronbach’s alpha coefficient for the official version of the Stroke Motivation Assessment Scale was 0.935, and the split-half reliability for the total scale was 0.801. The Cronbach’s alpha coefficient for each dimension ranged from 0.869 to 0.930, and the split-half reliability for each dimension ranged from 0.812 to 0.920. See Table 6.

Table 6 Internal Consistency Reliability and Split-Half Reliability of the Scale and Dimensions

Discussion

In this study, we used the following search terms to retrieve a substantial amount of literature to review: Protection Motivation, Protection Motivation Theory, PMT, Health Belief, Health Belief Model, HBM, Questionnaire and Scale. The searches were conducted using the PubMed, Web of Science, Embase, Cumulative Index to Nursing and Allied Health Literature, PsycINFO, China Journal Full-Text Database, CNKI, Wipu (VIP) and Wanfang databases, and the scale framework was finally formed. The relevant items were modified in two rounds using the Delphi method by 17 nursing experts, medical experts and mental and psychological nursing experts from the field of stroke care. The authority coefficient of the experts was 0.91, and the Kendall coordination coefficient of the two rounds of consultation was 0.502 for the first round and 0.409 for the second round, with a statistical significance (P < 0.05), all of which were within an acceptable range.

This scale used correlation analysis and factor analysis to retain and delete the scale items, and after two rounds of principal component analysis and maximum variance orthogonal rotation, six common factors were extracted. The cumulative contribution of variance was 71.82%, and each dimension was named according to the items. Correlation analysis was also conducted on the relationship between each dimension and the total scale, and the correlation coefficient was above 0.6, with a good correlation. Wu17 believed that the Cronbach’s alpha coefficient would be influenced by the number of scale items, and the larger the number of questions, the larger the Cronbach’s alpha coefficient. The Cronbach’s alpha coefficient for the total scale in this study was 0.935; the Cronbach’s alpha coefficients for the dimensions of severity, susceptibility, internal and external reward, response cost, response efficacy and self-efficacy were 0.930, 0.869, 0.908, 0.925, 0.917 and 0.889, respectively, all of which were greater than 0.80, indicating that the scale and each dimension had good stability.

Protection motivation is one of the manifestations of behavioural intentions in a broad sense. The assessment of protection motivation18,19 can not only provide an understanding of the level of patients’ behavioural intentions but also lay the foundation for identifying changes in behavioural intentions. Therefore, to implement secondary strategies, if the most influential variables on behavioural intentions of patients who have had a stroke can be identified, interventions can be carried out to target these variables, thus improving the relevance and effectiveness of related health education. Considering the advantages of PMT in improving the self-management behaviour of patients, scholars at home and abroad have widely applied nursing intervention based on this theory to diabetes,20 infectious diseases,21 tumours,22 health management,23 health education24 and other aspects and have achieved corresponding positive effects. Patients who have suffered a stroke have a heavy burden of disease, resulting in a high incidence and recurrence rate. Although stroke is a sudden disease, it can be affected by its long-term behaviour in the rehabilitation process. The application of the PMT in strokes has been widely considered, as it provides an effective solution to this condition and is expected to promote the health behaviour of patients experiencing their first stroke in the long term.

In this study, the theory of protective motivation was applied to the self-management of patients who had suffered a stroke, and a good self-management behaviour mechanism was established when the patient first developed. To some extent, it improved the quality of life of patients, improved self-management levels and provided a reference and basis for clinical practice. However, there were certain limitations in this study. First, since the convenient sampling method was used, the sample may lack representativeness, and the sampling deviation was large, making it difficult to accurately infer the overall outcome. Stricter sampling methods and larger multicentre studies should be implemented in the future. Second, because the study did not classify patients who had suffered a stroke, the results may not be highly persuasive. A follow-up study can be divided into three groups: patients in the recovery ward who have suffered a stroke, patients who have suffered a stroke with appointment follow-ups and patients who have suffered a stroke with overdue telephone follow-ups.

Conclusion

In this study, we preliminarily developed a Stroke Patient Protection Motivation Scale based on the PMT framework that could indirectly assess the behavioural intentions of patients who had suffered a stroke and assist in identifying variables that can predict behavioural intentions and actual behaviours in order to implement secondary prevention strategies. Additionally, the direct measurement of behavioural intentions and the measurement of actual behaviours in secondary prevention for patients who have had a stroke can be conducted in future targeted behavioural intervention studies based on the predictions presented in this study.

Data Sharing Statement

All data generated or analyzed during this study are included in this published article.

Ethical Statement

This study was conducted in accordance with the Declaration of Helsinki and approved by the ethics committee of Beijing Luhe Hospital of China Capital Medical University, and informed consent was obtained from all participants.

Author Contributions

All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

Funding

Research on the development and application of continuous nursing information platform for stroke patients in Beijing Tongzhou District Science and technology plan project (kj2017cx040-21).

Disclosure

The authors report no personal, financial, commercial, or academic conflicts of interest in this work.

References

1. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–1858.

2. Wang LD. Brief report on stroke prevention and treatment in China, 2019. Chin J Cerebrovasc Dis. 2020;17(5):272–281.

3. Ma L, Chao BH, Cao L, et al. The epidemiology and characteristics of stroke in China from 2007 to 2017: a national analysis. Chin J Cerebrovasc Dis. 2020;14(05):253–258.

4. Liu JF, Zheng LK, Cheng YJ, et al. Trends in outcomes of patients with ischemic stroke treated between 2002 and 2016: insights from a Chinese cohort. Circulation. 2019;12(12):1–10.

5. Manuilova IA, Sorokina MI, Cherniakov VL, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack (part 4). Stroke. 2011;42(1):227–276. doi:10.1161/STR.0b013e3181f7d043

6. Zhuo YY, Wu JM, Qu YM, et al. Clinical risk factors associated with recurrence of ischemic stroke within two years: a cohort study. Medicine. 2020;99(26):1–10. doi:10.1097/MD.0000000000020830

7. Hardie K, Hankey GJ, Jamrozik K, et al. Ten-year risk of first recurrent stroke and disability after first-ever stroke in the Perth Community Stroke Study. Stroke. 2004;35(3):731–735. doi:10.1161/01.STR.0000116183.50167.D9

8. Hankey GJ. Secondary stroke prevention. Lancet Neurol. 2014;13(2):178–194. doi:10.1016/S1474-4422(13)70255-2

9. Rothwell PM, Coull AJ, Giles MF, et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet. 2004;363(9425):1925–1933. doi:10.1016/S0140-6736(04)16405-2

10. Algra A, Wermer MJH. Stroke in 2016: stroke is treatable, but prevention is the key. Nat Rev Neurol. 2017;13(2):78–79. doi:10.1038/nrneurol.2017.4

11. Rothwell PM, Algra A, Chen ZM, et al. Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials. Lancet. 2016;388(10042):365–375. doi:10.1016/S0140-6736(16)30468-8

12. Yin ZK. A bibliometric analysis of secondary stroke prevention adherence studies. Proceedings of the 3rd Annual Academic Conference of the Chinese Stroke Association and Tiantan International Cerebrovascular Conference 2017. Beijing; 2017: 388–393.

13. Brouwer-Goossensen D, den Hertog HM, Mastenbroek-de Jong MA, van Gemert-Pijnen LJEWC, Taal E. Patient perspectives on health-related behavior change after transient ischemic attack or ischemic stroke. Brain Behav. 2021;11(4):e01993. doi:10.1002/brb3.1993

14. Brouwer-Goossensen D, Lingsma HF, Koudstaal PJ, den Hertog HM. The optimal timing of supporting patients in health-related behavior change after TIA or ischemic stroke: a prospective cohort study to determinants of health-related intention to change over time. Int J Rehabil Res. 2021;44(1):32–37. doi:10.1097/MRR.0000000000000443

15. DeVellis RF, Thorpe CT. Scale Development Theory and Application Original Book. 3rd ed. Chongqing: Chongqing University Press; 2016.

16. Romero-Collado A. Essential elements to elaborate a study with the (e)Delphi method. Enferm Intensiva. 2021;32(2):100–104. doi:10.1016/j.enfi.2020.09.001

17. Ming-Lung W. Statistical Analysis of Questionnaires in Practice SPSS Operations and Applications. Chongqing: Chongqing University Press; 2010.

18. Rogers RW. A protection motivation theory of fear appeals and attitude change 1. J Psychol. 1975;91(1):93–114. doi:10.1080/00223980.1975.9915803

19. Webb TL, Sniehotta FF, Michie S. Using theories of behaviour change to inform interventions for addictive behaviours. Addiction. 2010;105(11):1879–1892. doi:10.1111/j.1360-0443.2010.03028.x

20. Hassan S. Application of protection motivation theory to diabetic foot care Behaviours in Egypt. J Diabetes Metab Disord. 2020;19(2):869–873. doi:10.1007/s40200-020-00573-6

21. Nudelman G, Kamble SV, Otto K. Using protection motivation theory to predict adherence to COVID-19 behavioral guidelines. Behav Med. 2022;10:1–10. doi:10.1080/08964289.2021.2021383

22. Sotoudeh A, Mazloomy Mahmoodabad SS, Vaezi AA, Fattahi Ardakani M, Sadeghi R. Determining skin cancer protective behaviors in the light of the protection motivation theory among sailors in Bandar-Bushehr in the South of Iran. Asian Pac J Cancer Prev. 2020;21(12):3551–3556. doi:10.31557/APJCP.2020.21.12.3551

23. Bui L, Mullan B, McCaffery K. Protection motivation theory and physical activity in the general population: a systematic literature review. Psychol Health Med. 2013;18(5):522–542. doi:10.1080/13548506.2012.749354

24. Kimhasawad W, Punyanirun K, Somkotra T, Detsomboonrat P, Trairatvorakul C, Songsiripradubboon S. Comparing protection-motivation theory-based intervention with routine public dental health care. Int J Dent Hyg. 2021;19(3):279–286. doi:10.1111/idh.12522

Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.